ClinicalTrials.gg
RecruitingNCT06303492Updated Oct 28, 2026

Aspiration Risk Assessment by Gastric Ultrasound in eMErgency Surgery and ANesThetic Decision-making: The ARGUMENT Study

An interventional study of GUS in Pulmonary Aspiration and Emergency Surgery, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.
Updated Oct 28, 2026Now RecruitingFirst site in Canada+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
142
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Pulmonary aspiration of gastric contents is a serious patient safety problem accounting for 50% of anesthesia-related mortality. The risk is higher in patients undergoing emergency surgery as the gastric content is uncertain which poses a challenge to anesthetic decision-making. Standard clinical assessment to identify at-risk patients primarily relies on preoperative fasting guidelines and is not adequate for patients undergoing emergency surgeries. Point-of-care gastric ultrasound (GUS) has emerged as an accurate bedside tool providing information regarding the type and volume of gastric contents. When GUS was added to standard clinical assessment, anesthetic management plan changed in 71% of adult elective and 37% of pediatric emergency surgical procedures. Such data is lacking in adult patients undergoing emergency surgeries. The investigators propose a multicentre mixed-method study to evaluate the impact of GUS on aspiration risk assessment and subsequent Anesthetic Plan before emergency surgeries. The evidence from this study will improve patient safety by accurately identifying patients at risk of aspiration and tailoring anesthetic techniques and airway management to prevent pulmonary aspiration in patients undergoing emergency surgeries.

Read the detailed description

The proposed trial design is a mixed-method, multicenter study that includes a randomized controlled trial (RCT) and a qualitative assessment component. The RCT will evaluate the impact of adding GUS to the standard clinical assessment on the incidence of changes in the anesthetic plan for adult patients undergoing emergency surgery. The qualitative assessment will gather attending anesthesiologists' opinions on the addition of GUS in an emergency surgical setting.

02

Conditions studied

  • Pulmonary Aspiration
  • Emergency Surgery
03

In context

Lead sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 138 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >18 years
  • ' (ASA) physical status I-III
  • Patients scheduled for non-elective non-cardiac surgery.

Exclusion criteria

Exclusion Criteria:

  • Abnormal anatomy of the upper gastro-intestinal tract (including hiatus hernia, gastric tumors, and previous surgeries of the upper gastrointestinal tract).
  • Extrinsic gastric compression obtained from the medical history or during the actual ultrasound examination.
  • Pregnancy.
  • Attending anesthesiologist refusal to include the patient for participation in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
142 participants (estimated)

Study arms

  • Experimental
    Gastric ultrasound (GUS) group

    Aspiration risk assessment using GUS in addition to the standard clinical assessment.

    Procedure: GUS

  • No intervention
    Control

    Aspiration risk assessment only by standard clinical assessment, and no GUS

Interventions

  • ProcedureGUS

    Aspiration risk assessment by GUS

06

What researchers measure

Primary outcomes

  1. Proportion of change in Anesthetic Plan

    The primary outcome of the study is a change from the initial anesthetic plan after viewing GUS results in the intervention group, and after being given the opportunity to revise the plan in the control group.

    Time frame: Baseline

Secondary outcomes

  1. Percentage change in the three-category risk assessment before and after GUS

    The secondary aim is only related to the intervention group, (1) to compare the aspiration risk assessment categories between the standard clinical assessment and GUS examination

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2024 (actual). Primary completion is estimated for Dec 2027, 42 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 28, 2026: start May 2024 → Jun 2024, primary completion Dec 2025 → Dec 2027 and completion Apr 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2024
First posted
Mar 12, 2024
StartActual
Jun 5, 2024was May 2024
Primary completionEst.
Dec 12, 2027was Dec 2025
CompletionEst.
Dec 30, 2027was Apr 2026
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 28, 2026
Sites
1 site added — first site in Canada
Show site
  • Department of Anesthesia Mount Sinai Hospital · Toronto, Canada
Oct 28, 2026
Start date
May 2024→Jun 5, 2024 (actual)
Oct 28, 2026
Primary completion
Dec 2025→Dec 12, 2027
Oct 28, 2026
Study completion
Apr 2026→Dec 30, 2027
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Canada
    Show site
    • Department of Anesthesia Mount Sinai Hospital · Toronto, Canada
    Start date May 2024→Jun 5, 2024 (now actual)
    Primary completion Dec 2025→Dec 12, 2027
    Study completion Apr 2026→Dec 30, 2027
    + 2 other changes: verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06303492
Responsible party
Sponsor
First posted
Mar 12, 2024
Start date
Jun 5, 2024
Primary completion
Dec 12, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Oct 28, 2026

Study contacts

Cristian Arzola, MD, MSc
Contact
cristian.arzola@sinaihealth.ca
416-586-4800 ext. 5270
Jonathan Sy
Contact
Jonathan.Sy@sinaihealth.ca

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion